Clinical Trial Update: Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating intensive golimumab treatment in ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Golimumab (golimumab)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: ULCERATIVE COLITIS | Phase 4 | Status: COMPLETED